A human protein called RBBP6 helps fight the Ebola virus by interfering with the virus replication cycle, according to a study recently published in Cell.
Yearly Archives: 2018
Men with inflammatory bowel disease have four to five times higher risk of prostate cancer, according to a new 20-year study.
Inhibiting CHAF1B, a protein that normally helps replenish blood cells, may be a promising treatment for leukemia, according to a recent study.
Farzaneh Sorond, MD, PhD, has been named the new associate dean for Faculty Development for Northwestern University Feinberg School of Medicine.
Feinberg faculty, staff, students and community partners gathered at the inaugural IPHAM Population Health Forum to share their experience improving the health of communities in Chicago and around the world.
From fundamental new understandings of the cell published in Nature to landmark clinical trials in the New England Journal of Medicine and cross-disciplinary collaborations in Science Translational Medicine, investigators throughout our institution have advanced new knowledge that is already transforming their diverse fields.
Northwestern scientists specializing in HIV and AIDS gathered to share their experiences during a panel held December 3, to commemorate World AIDS Day.
The world’s smallest wearable device has been developed by Northwestern scientists, to measure exposure to light across multiple wavelengths.
A Northwestern Medicine study has revealed new insights into a pathway in prostate cancer and identified a potential new therapeutic target for aggressive disease.
The 40th performance of In Vivo, Feinberg students’ annual sketch comedy and variety show, raised money for a Chicago-area charity that helps homeless women.